Use of natural killer cells as immunotherapy for leukaemia.
about
MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment.Opportunities and limitations of natural killer cells as adoptive therapy for malignant diseaseQuality assessment of cellular therapies: the emerging role of molecular assays.Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individualsA perspective on the selection of unrelated donors and cord blood units for transplantationCellular therapies in acute lymphoblastic leukemiaUmbilical cord blood immunology: relevance to stem cell transplantation.NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome.A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy.Cellular therapies in acute lymphoblastic leukemia.CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.Partial break in tolerance of NKG2A-/LIR-1- single KIR+ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation.
P2860
Q34161539-AD44D92B-49DB-434A-98BF-D7F4A14E34D0Q34307792-60AB94E6-B5C2-4281-B9F7-5E5E12AA41DBQ34316777-B3F2A722-BB76-4125-BA38-B40F6D5E7974Q34471812-E351766E-9336-4B74-80E8-568EC7983B01Q36100445-7F7DA4B1-3CC2-42C8-8A81-A8F89AE892E6Q36552098-042B13AE-28E6-400E-9C4E-0D9274EF14B5Q37963798-884ECD60-2E16-4447-BB64-637EC741A01AQ38057238-9BB4EA82-4B0E-4ECB-95A0-A21AFE67ACAEQ38766781-4D472AC4-9A74-4E95-9622-496CEF5D0B4AQ41560177-15CE622F-1086-46A9-9D76-120752AAB29AQ41991684-4D09585E-0FEE-4EB3-8C75-C6936B608553Q44893639-722831FB-5045-45C5-9FDD-A15AB693282EQ53307480-600DA085-D052-40F4-A8A1-2E8A59E957FB
P2860
Use of natural killer cells as immunotherapy for leukaemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Use of natural killer cells as immunotherapy for leukaemia.
@en
type
label
Use of natural killer cells as immunotherapy for leukaemia.
@en
prefLabel
Use of natural killer cells as immunotherapy for leukaemia.
@en
P2860
P1476
Use of natural killer cells as immunotherapy for leukaemia
@en
P2093
Bartosz Grzywacz
Michael R Verneris
P2860
P304
P356
10.1016/J.BEHA.2008.07.008
P577
2008-09-01T00:00:00Z